{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:47:01Z","timestamp":1792180021988,"version":"4.4.0"},"reference-count":170,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.semarthrit.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T09:01:14Z","timestamp":1547197274000},"page":"9-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":227,"title":["Type 2 diabetes mellitus and osteoarthritis"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-289X","authenticated-orcid":false,"given":"Nicola","family":"Veronese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3510-0709","authenticated-orcid":false,"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Al-Daghri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3241-991X","authenticated-orcid":false,"given":"Gabriel","family":"Herrero-Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1939-3652","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Kaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Maheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio C.","family":"Rovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Uebelhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Vlaskovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Scheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"9859","key":"10.1016\/j.semarthrit.2019.01.005_bib0002","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.semarthrit.2019.01.005_bib0003","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/annrheumdis-2013-205012","article-title":"The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis: the NEO study","volume":"74","author":"Visser","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0004","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12263-014-0406-6","article-title":"High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes","volume":"9","author":"Teodoro","year":"2014","journal-title":"Genes Nutr"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.01.005_bib0005","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-8587(14)70004-X","article-title":"Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes","volume":"2","author":"Scheen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0006","series-title":"Centers for disease control and prevention: national diabetes statistics report","year":"2017"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0008","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"issue":"9631","key":"10.1016\/j.semarthrit.2019.01.005_bib0009","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(08)60932-0","article-title":"Type 2 diabetes: pathogenesis and treatment","volume":"371","author":"Stumvoll","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.joca.2015.03.031","article-title":"The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms","volume":"23","author":"King","year":"2015","journal-title":"Osteoarthr Cartil"},{"issue":"44","key":"10.1016\/j.semarthrit.2019.01.005_bib0011","first-page":"869","article-title":"Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation \u2013 United States, 2010-2012","volume":"62","year":"2013","journal-title":"Morb Mortal Wkly Rep"},{"issue":"9783","key":"10.1016\/j.semarthrit.2019.01.005_bib0012","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","article-title":"Osteoarthritis: an update with relevance for clinical practice","volume":"377","author":"Bijlsma","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0013","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/ard.2008.106930","article-title":"Association between weight or body mass index and hand osteoarthritis: a systematic review","volume":"69","author":"Yusuf","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000077","article-title":"Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis","volume":"1","author":"Louati","year":"2015","journal-title":"RMD Open"},{"issue":"9491","key":"10.1016\/j.semarthrit.2019.01.005_bib0015","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2013a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3810\/pgm.2009.11.2073","article-title":"Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data","volume":"121","author":"Puenpatom","year":"2009","journal-title":"Postgrad Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2019.01.005_bib0017","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrrheum.2012.135","article-title":"Metabolic syndrome meets osteoarthritis","volume":"8","author":"Zhuo","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"16","key":"10.1016\/j.semarthrit.2019.01.005_bib0018","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.01.005_bib0019","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40520-017-0808-6","article-title":"Association between the severity of symptomatic knee osteoarthritis and cumulative metabolic factors","volume":"30","author":"Yasuda","year":"2018","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/annrheumdis-2014-206914","article-title":"Paracetamol: not as safe as we thought? A systematic literature review of observational studies","volume":"75","author":"Roberts","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12882-016-0411-7","article-title":"High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study","volume":"17","author":"Lipworth","year":"2016","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0022","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.2337\/dc16-2200","article-title":"Potential hypoxic renal injury in patients with diabetes on SGLT2 inhibitors: caution regarding concomitant use of nsaids and iodinated contrast media","volume":"40","author":"Heyman","year":"2017","journal-title":"Diabetes Care"},{"issue":"9894","key":"10.1016\/j.semarthrit.2019.01.005_bib0023","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.semarthrit.2019.01.005_bib0024","doi-asserted-by":"crossref","first-page":"e3739","DOI":"10.1097\/MD.0000000000003739","article-title":"Severity of diabetes mellitus and total hip or knee replacement: a population-based case-control study","volume":"95","author":"Nielen","year":"2016","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.semarthrit.2019.01.005_bib0025","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.2005.045724","article-title":"Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam study","volume":"66","author":"Dahaghin","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0026","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/acr.22460","article-title":"Diabetes is associated with increased hand pain in erosive hand osteoarthritis: data from a population-based study","volume":"67","author":"Magnusson","year":"2015","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.semarthrit.2019.01.005_bib0027","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.joca.2016.04.005","article-title":"Type II diabetes mellitus and incident osteoarthritis of the hand: a population-based case-control analysis","volume":"24","author":"Frey","year":"2016","journal-title":"Osteoarthr Cartil"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0028","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.joca.2015.01.013","article-title":"Diabetes is a risk factor for knee osteoarthritis progression","volume":"23","author":"Eymard","year":"2015","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0029","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/dc12-0924","article-title":"Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study","volume":"36","author":"Schett","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00296-017-3676-7","article-title":"Effects of medication-treated diabetes on incidence and progression of knee osteoarthritis: a longitudinal analysis of the osteoarthritis initiative data","volume":"37","author":"Shirinsky","year":"2017","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0031","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S1463423617000287","article-title":"Does metformin protect against osteoarthritis? An electronic health record cohort study","volume":"18","author":"Barnett","year":"2017","journal-title":"Prim Health Care Res Dev"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191242","article-title":"Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: a nationwide, retrospective, matched-cohort study in Taiwan","volume":"13","author":"Lu","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0033","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diabet.2015.02.003","article-title":"Antidiabetic agents: potential anti-inflammatory activity beyond glucose control","volume":"41","author":"Scheen","year":"2015","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0034","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/bcp.12786","article-title":"Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case-control study","volume":"81","author":"Nielen","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diabres.2016.10.021","article-title":"Osteoarthritis and type 2 diabetes mellitus: what are the links?","volume":"122","author":"Courties","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.01.005_bib0036","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.joca.2015.05.016","article-title":"Metabolic stress-induced joint inflammation and osteoarthritis","volume":"23","author":"Courties","year":"2015","journal-title":"Osteoarthr Cartil"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.01.005_bib0037","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.joca.2007.09.007","article-title":"Effect of fatty acids on bone marrow lesions and knee cartilage in healthy, middle-aged subjects without clinical knee osteoarthritis","volume":"16","author":"Wang","year":"2008","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0038","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mehy.2016.12.010","article-title":"Serum insulin in pathogenesis and treatment of osteoarthritis","volume":"99","author":"Askari","year":"2017","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0039","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000441418","article-title":"Knee osteoarthritis in type 2 diabetes mellitus: does insulin therapy retard osteophyte formation?","volume":"25","author":"Al-Jarallah","year":"2016","journal-title":"Med Princ Pract"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.joca.2011.02.004","article-title":"Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin","volume":"19","author":"Rosa","year":"2011","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0041","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.joca.2015.10.017","article-title":"Insulin decreases autophagy and leads to cartilage degradation","volume":"24","author":"Ribeiro","year":"2016","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0042","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0043","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/art.39586","article-title":"Editorial: insulin resistance: releasing the brakes on synovial inflammation and osteoarthritis?","volume":"68","author":"Griffin","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0044","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/art.39561","article-title":"Suppressive effects of insulin on tumor necrosis factor-dependent early osteoarthritic changes associated with obesity and type 2 diabetes mellitus","volume":"68","author":"Hamada","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/BOR.0000000000000373","article-title":"Metabolic syndrome-associated osteoarthritis","volume":"29","author":"Courties","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0046","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/cbir.2001.0850","article-title":"Human articular chondrocytes express three facilitative glucose transporter isoforms: GLUT1, GLUT3 and GLUT9","volume":"26","author":"Mobasheri","year":"2002","journal-title":"Cell Biol Int"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0047","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar2713","article-title":"Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage","volume":"11","author":"Rosa","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0048","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13075-017-1226-z","article-title":"Sex differences in the association of skin advanced glycation endproducts with knee osteoarthritis progression","volume":"19","author":"Eaton","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0049","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.joca.2013.03.006","article-title":"Skin pentosidine in very early hip\/knee osteoarthritis (CHECK) is not a strong independent predictor of radiographic progression over 5 years follow-up","volume":"21","author":"Vos","year":"2013","journal-title":"Osteoarthr Cartil"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0050","doi-asserted-by":"crossref","first-page":"e66611","DOI":"10.1371\/journal.pone.0066611","article-title":"Advanced glycation end products induce peroxisome proliferator-activated receptor gamma down-regulation-related inflammatory signals in human chondrocytes via toll-like receptor-4 and receptor for advanced glycation end products","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0051","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.bbagen.2012.12.017","article-title":"High glucose induces vascular endothelial growth factor production in human synovial fibroblasts through reactive oxygen species generation","volume":"1830","author":"Tsai","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.semarthrit.2019.01.005_bib0052","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.joca.2016.06.019","article-title":"Diabetes-accelerated experimental osteoarthritis is prevented by autophagy activation","volume":"24","author":"Ribeiro","year":"2016","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0053","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.maturitas.2012.05.013","article-title":"Increased fasting serum glucose concentration is associated with adverse knee structural changes in adults with no knee symptoms and diabetes","volume":"72","author":"Davies-Tuck","year":"2012","journal-title":"Maturitas"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.01.005_bib0054","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.joca.2013.06.027","article-title":"Bone loss at subchondral plate in knee osteoarthritis patients with hypertension and type 2 diabetes mellitus","volume":"21","author":"Wen","year":"2013","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0055","first-page":"650","article-title":"Advanced glycation end products affect growth and function of osteoblasts","volume":"29","author":"Franke","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"405","key":"10.1016\/j.semarthrit.2019.01.005_bib0056","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/pgmj.35.405.384","article-title":"Periarthritis of the shoulder","volume":"35","author":"Charnley","year":"1959","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0057","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0363-5023(84)80185-9","article-title":"Microvascular changes in Dupuytren's contracture","volume":"9","author":"Kischer","year":"1984","journal-title":"J Hand Surg"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0058","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1534734606292281","article-title":"Microvascular changes in the diabetic foot","volume":"5","author":"Schramm","year":"2006","journal-title":"Int J Low Extrem Wounds"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0059","first-page":"285","article-title":"Vascular anatomy and microcirculation of skeletal zones vulnerable to osteonecrosis: vascularization of the femoral head","volume":"35","author":"Johnson","year":"2004","journal-title":"Orthop Clin"},{"issue":"12","key":"10.1016\/j.semarthrit.2019.01.005_bib0060","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/rheumatology\/kem191","article-title":"Vascular pathology and osteoarthritis","volume":"46","author":"Findlay","year":"2007","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.01.005_bib0061","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.med.0000433056.76699.5d","article-title":"Lifestyle medicine: the future of chronic disease management","volume":"20","author":"Kushner","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0062","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","article-title":"An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"44","author":"Bruyere","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl. 1","key":"10.1016\/j.semarthrit.2019.01.005_bib0063","first-page":"S38","article-title":"American Diabetes Association. 4. Lifestyle management: standards of medical care in diabetes 2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0064","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1249\/JSR.0000000000000249","article-title":"Call to action on making physical activity assessment and prescription a medical standard of care","volume":"15","author":"Sallis","year":"2016","journal-title":"Curr Sports Med Rep"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0065","article-title":"Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus","volume":"12","author":"Hemmingsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0066","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00003677-200307000-00006","article-title":"Can a physically active lifestyle prevent type 2 diabetes?","volume":"31","author":"Kriska","year":"2003","journal-title":"Exerc Sport Sci Rev"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0067","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"issue":"18","key":"10.1016\/j.semarthrit.2019.01.005_bib0068","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0069","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"9702","key":"10.1016\/j.semarthrit.2019.01.005_bib0070","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0071","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/jes.0b013e31815e3dc5","article-title":"Autonomic regulation of the association between exercise and diabetes","volume":"36","author":"Carnethon","year":"2008","journal-title":"Exerc Sport Sci Rev"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0072","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000357334","article-title":"Exercise interventions to prevent and manage type 2 diabetes: physiological mechanisms","volume":"60","author":"Dela","year":"2014","journal-title":"Med Sport Sci"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0073","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7861\/clinmedicine.14-6-673","article-title":"Diabetes and exercise","volume":"14","author":"Lumb","year":"2014","journal-title":"Clin Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0074","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing diabetes prevention study: a 23-year follow-up study","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0075","article-title":"Acetaminophen for osteoarthritis","author":"Towheed","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0076","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0077","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/bcp.12635","article-title":"Liver transplant associated with paracetamol overdose: results from the seven-country SALT study","volume":"80","author":"Gulmez","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0078","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2125.2011.04067.x","article-title":"Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity","volume":"73","author":"Craig","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0079","doi-asserted-by":"crossref","first-page":"h1225","DOI":"10.1136\/bmj.h1225","article-title":"Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials","volume":"350","author":"Machado","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1210\/er.2012-1009","article-title":"Diabetes and nonalcoholic fatty liver disease: a pathogenic duo","volume":"34","author":"Williams","year":"2013","journal-title":"Endocr Rev"},{"issue":"39","key":"10.1016\/j.semarthrit.2019.01.005_bib0081","doi-asserted-by":"crossref","first-page":"e8179","DOI":"10.1097\/MD.0000000000008179","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis","volume":"96","author":"Dai","year":"2017","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0082","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2019.01.005_bib0083","first-page":"212","article-title":"Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity","volume":"3","author":"Massart","year":"2017","journal-title":"J Clin Transl Res"},{"issue":"7","key":"10.1016\/j.semarthrit.2019.01.005_bib0084","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1111\/liv.12514","article-title":"Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease","volume":"34","author":"Michaut","year":"2014","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00228-017-2356-6","article-title":"Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature","volume":"74","author":"Caparrotta","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.01.005_bib0086","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/1440-1681.12886","article-title":"Role of mitochondria and mitochondria-targeted agents in non-alcoholic fatty liver disease","volume":"45","author":"Ajith","year":"2018","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0087","doi-asserted-by":"crossref","first-page":"G329","DOI":"10.1152\/ajpgi.00361.2009","article-title":"Diabetic KK-A(y) mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen","volume":"299","author":"Kon","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0088","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2015.02.008","article-title":"Metformin ameliorates acetaminophen hepatotoxicity via Gadd45beta-dependent regulation of JNK signaling in mice","volume":"63","author":"Kim","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0089","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/kfw158","article-title":"Editor's highlight: metformin protects against acetaminophen hepatotoxicity by attenuation of mitochondrial oxidant stress and dysfunction","volume":"154","author":"Du","year":"2016","journal-title":"Toxicol Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0090","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/bcp.12802","article-title":"Can paracetamol (acetaminophen) be administered to patients with liver impairment?","volume":"81","author":"Hayward","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0091","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2125.1993.tb05672.x","article-title":"Paracetamol elimination in patients with non-insulin dependent diabetes mellitus","volume":"35","author":"Kamali","year":"1993","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.01.005_bib0092","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.4103\/1735-1995.172845","article-title":"Diabetes mellitus and renal failure: prevention and management","volume":"20","author":"Nasri","year":"2015","journal-title":"J Res Med Sci: Off J Isfahan Univ Med Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0093","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/11531250-000000000-00000","article-title":"Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study","volume":"27","author":"Pratt","year":"2010","journal-title":"Drugs Aging"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.01.005_bib0094","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2165\/00002018-200831110-00004","article-title":"NSAID use in individuals at risk of renal adverse events: an observational study to investigate trends in Australian veterans","volume":"31","author":"Roughead","year":"2008","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2004.12.005","article-title":"Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population","volume":"45","author":"Huerta","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0096","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/fcp.12014","article-title":"Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database","volume":"28","author":"Fournier","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0097","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2015.101","article-title":"Combined use of nonsteroidal anti-inflammatory drugs with diuretics and\/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury","volume":"88","author":"Dreischulte","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0098","doi-asserted-by":"crossref","first-page":"e8525","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.semarthrit.2019.01.005_bib0099","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.annepidem.2014.05.001","article-title":"Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999-2010","volume":"24","author":"Wong","year":"2014","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40265-014-0337-y","article-title":"Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus","volume":"75","author":"Scheen","year":"2015","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.semarthrit.2019.01.005_bib0101","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11892-016-0789-4","article-title":"SGLT2 inhibitors: benefit\/risk balance","volume":"16","author":"Scheen","year":"2016","journal-title":"Curr Diab Rep"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0102","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40264-017-0602-6","article-title":"Can SGLT2 inhibitors cause acute renal failure? plausible role for altered glomerular hemodynamics and medullary hypoxia","volume":"41","author":"Szalat","year":"2018","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0103","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X12666160606120254","article-title":"Type 2 diabetes and heart failure: challenges and solutions","volume":"12","author":"Thomas","year":"2016","journal-title":"Curr Cardiol Rev"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0104","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/CRD.0b013e3181ce1521","article-title":"Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale","volume":"18","author":"Amer","year":"2010","journal-title":"Cardiol Rev"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/14740338.5.1.83","article-title":"Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs","volume":"5","author":"Maillard","year":"2006","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0106","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jcpt.12484","article-title":"Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis","volume":"42","author":"Gunter","year":"2017","journal-title":"J Clin Pharm Ther"},{"issue":"26","key":"10.1016\/j.semarthrit.2019.01.005_bib0107","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0108","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/art.40400","article-title":"Differences in safety of nonsteroidal antiinflammatory drugs in patients with osteoarthritis and patients with rheumatoid arthritis: a randomized clinical trial","volume":"70","author":"Solomon","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0109","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.165.2.161","article-title":"The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus","volume":"165","author":"Sowers","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0110","doi-asserted-by":"crossref","first-page":"k3426","DOI":"10.1136\/bmj.k3426","article-title":"Diclofenac use and cardiovascular risks: series of nationwide cohort studies","volume":"362","author":"Schmidt","year":"2018","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0111","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5414\/CP203071","article-title":"Prospective study of NSAIDs prescribing in Saudi Arabia: cardiovascular and gastrointestinal risk in patients with diabetes mellitus","volume":"56","author":"Mazhar","year":"2018","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0112","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3810\/pgm.2010.11.2227","article-title":"Topical nonsteroidal anti-inflammatory drugs for osteoarthritis","volume":"122","author":"Barthel","year":"2010","journal-title":"Postgrad Med"},{"issue":"4 Suppl","key":"10.1016\/j.semarthrit.2019.01.005_bib0113","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.semarthrit.2015.11.007","article-title":"Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys","volume":"45","author":"Rannou","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0114","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2147\/CIA.S35416","article-title":"Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities","volume":"7","author":"Peniston","year":"2012","journal-title":"Clin Interv Aging"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjopharm.2011.12.002","article-title":"Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities","volume":"10","author":"Baraf","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"issue":"9252","key":"10.1016\/j.semarthrit.2019.01.005_bib0116","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.semarthrit.2019.01.005_bib0117","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","article-title":"Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study","volume":"162","author":"Pavelka","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0118","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.joca.2012.09.017","article-title":"Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study","volume":"21","author":"Zegels","year":"2013","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0119","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/art.24255","article-title":"Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial","volume":"60","author":"Kahan","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2019.01.005_bib0120","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.joca.2006.06.010","article-title":"Commentary: osteoarthritis of the knee and glucosamine","volume":"14","author":"Altman","year":"2006","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0121","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/annrheumdis-2012-202485","article-title":"Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study","volume":"73","author":"Maheu","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2019.01.005_bib0122","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.22852","article-title":"The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest","volume":"56","author":"Reginster","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2019.01.005_bib0123","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2016-210860","article-title":"Pharmaceutical-grade chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)","volume":"76","author":"Reginster","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0124","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40266-016-0347-4","article-title":"Diacerein: benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO","volume":"33","author":"Pavelka","year":"2016","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1947603514554992","article-title":"Management of osteoarthritis with avocado\/soybean unsaponifiables","volume":"6","author":"Christiansen","year":"2015","journal-title":"Cartilage"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0126","article-title":"Glucosamine therapy for treating osteoarthritis","author":"Towheed","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0127","doi-asserted-by":"crossref","first-page":"c4675","DOI":"10.1136\/bmj.c4675","article-title":"Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis","volume":"341","author":"Wandel","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.yrtph.2006.07.004","article-title":"Risk assessment for glucosamine and chondroitin sulfate","volume":"47","author":"Hathcock","year":"2007","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0129","article-title":"Chondroitin for osteoarthritis","volume":"1","author":"Singh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40520-018-0911-3","article-title":"Diacerein-containing products: same risk of diarrhoea?","volume":"30","author":"Pelletier","year":"2018","journal-title":"Aging Clin Exp Res"},{"issue":"10","key":"10.1016\/j.semarthrit.2019.01.005_bib0131","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.lpm.2010.01.013","article-title":"Reseau francais des centres regionaux de p. [Post-marketing safety profile of avocado-soybean unsaponifiables]","volume":"39","author":"Olivier","year":"2010","journal-title":"Presse Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0132","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0021-9258(19)75908-0","article-title":"Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance","volume":"262","author":"Garvey","year":"1987","journal-title":"J Biol Chem."},{"issue":"8","key":"10.1016\/j.semarthrit.2019.01.005_bib0133","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1016\/S0021-9258(19)67706-9","article-title":"Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance","volume":"266","author":"Marshall","year":"1991","journal-title":"J Biol Chem."},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0134","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1172\/JCI118349","article-title":"Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity","volume":"96","author":"Baron","year":"1995","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.01.005_bib0135","first-page":"2099","article-title":"Short-term glucosamine infusion does not affect insulin sensitivity in humans","volume":"86","author":"Pouwels","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0136","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/diabetes.49.6.926","article-title":"Effects of glucosamine infusion on insulin secretion and insulin action in humans","volume":"49","author":"Monauni","year":"2000","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.01.005_bib0137","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.2337\/db06-0714","article-title":"Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects","volume":"55","author":"Muniyappa","year":"2006","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.semarthrit.2019.01.005_bib0138","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0139","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/1874312901105010069","article-title":"Crystalline glucosamine sulfate in the treatment of osteoarthritis: evidence of long-term cardiovascular safety from clinical trials","volume":"5","author":"Palma Dos Reis","year":"2011","journal-title":"Open Rheumatol J"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.22371","article-title":"Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator","volume":"56","author":"Herrero-Beaumont","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0141","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.joca.2011.01.007","article-title":"The effect of glucosamine on glucose metabolism in humans: a systematic review of the literature","volume":"19","author":"Dostrovsky","year":"2011","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0142","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/dmrr.1150","article-title":"A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals","volume":"27","author":"Simon","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0143","doi-asserted-by":"crossref","first-page":"731-7 e6","DOI":"10.1016\/j.amjmed.2016.11.038","article-title":"The effect of prolonged glucosamine usage on HbA1c Levels and new-onset diabetes mellitus in overweight and obese middle-aged women","volume":"130","author":"Gommans","year":"2017","journal-title":"Am J Med"},{"issue":"Suppl 4S","key":"10.1016\/j.semarthrit.2019.01.005_bib0144","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.semarthrit.2015.11.001","article-title":"The role of diet & exercise and of glucosamine sulfate in the prevention of knee osteoarthritis: further results from the Prevention of Knee Osteoarthritis in Overweight Females (PROOF) study","volume":"45","author":"Runhaar","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0145","unstructured":"Mylan. DONA (crystalline glucosamine sulfate1500 mg powder): summary of product characteristics 2018 2018."},{"issue":"7","key":"10.1016\/j.semarthrit.2019.01.005_bib0146","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10067-009-1135-x","article-title":"Systemic effects of intra-articular corticosteroids","volume":"28","author":"Habib","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0147","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.RVW.O.00029","article-title":"Blood glucose levels following intra-articular steroid injections in patients with diabetes: a systematic review","volume":"4","author":"Choudhry","year":"2016","journal-title":"JBJS Rev"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40520-015-0522-1","volume":"28","author":"Cooper","year":"2016","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.01.005_bib0149","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.semarthrit.2013.10.002","article-title":"Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis","volume":"43","author":"Bannuru","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2019.01.005_bib0150","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/art.24925","article-title":"Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis","volume":"61","author":"Bannuru","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2019.01.005_bib0151","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.joca.2016.07.010","article-title":"Comparative safety profile of hyaluronic acid products for knee osteoarthritis: a systematic review and network meta-analysis","volume":"24","author":"Bannuru","year":"2016","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0152","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M14-1231","article-title":"Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis","volume":"162","author":"Bannuru","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0153","article-title":"Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: results of an extensive critical literature review","author":"Maheu","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2019.01.005_bib0154","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/acr.23204","article-title":"Use of intraarticular hyaluronic acid in the management of knee osteoarthritis in clinical practice","volume":"69","author":"Cooper","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"4 Suppl","key":"10.1016\/j.semarthrit.2019.01.005_bib0155","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.semarthrit.2015.11.008","article-title":"Efficacy and safety of hyaluronic acid in the management of osteoarthritis: evidence from real-life setting trials and surveys","volume":"45","author":"Maheu","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2019.01.005_bib0156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145776","article-title":"Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: evidence from a large U.S. health claims database","volume":"10","author":"Altman","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0157","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/dth.12153","article-title":"Effectiveness of hyaluronic acid for treating diabetic foot: a systematic review and meta-analysis","volume":"27","author":"Chen","year":"2014","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.01.005_bib0158","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrrheum.2012.224","article-title":"Tackling obesity in knee osteoarthritis","volume":"9","author":"Wluka","year":"2013","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.01.005_bib0159","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.soard.2016.09.011","article-title":"Obesity and the role of bariatric surgery in the surgical management of osteoarthritis of the hip and knee: a review of the literature","volume":"13","author":"Springer","year":"2017","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0160","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc16-0236","article-title":"Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations","volume":"39","author":"Rubino","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.01.005_bib0161","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jacc.2017.12.014","article-title":"Metabolic surgery: weight loss, diabetes, and beyond","volume":"71","author":"Pareek","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0162","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13098-015-0012-9","article-title":"Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes","volume":"7","author":"Lindegaard","year":"2015","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.01.005_bib0163","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MED.0000000000000277","article-title":"The impact of bariatric surgery on inflammation: quenching the fire of obesity?","volume":"23","author":"Hafida","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.semarthrit.2019.01.005_bib0164","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fimmu.2017.01512","article-title":"Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes","volume":"8","author":"Yadav","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1574887113666180314095445","article-title":"Bariatric surgery and rheumatic diseases: a literature review","volume":"13","author":"Gallo","year":"2018","journal-title":"Rev Recent Clin Trials"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.01.005_bib0166","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/obr.12236","article-title":"Effects of bariatric surgery for knee complaints in (morbidly) obese adult patients: a systematic review","volume":"16","author":"Groen","year":"2015","journal-title":"Obes Rev"},{"issue":"13","key":"10.1016\/j.semarthrit.2019.01.005_bib0167","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.2016.3010","article-title":"Change in pain and physical function following bariatric surgery for severe obesity","volume":"315","author":"King","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.semarthrit.2019.01.005_bib0168","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1302\/0301-620X.98B9.38024","article-title":"Does bariatric surgery prior to total hip or knee arthroplasty reduce post-operative complications and improve clinical outcomes for obese patients? Systematic review and meta-analysis","volume":"98-B","author":"Smith","year":"2016","journal-title":"Bone Joint J"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0169","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.soard.2016.11.005","article-title":"Benefits of bariatric surgery before elective total joint arthroplasty: is there a role for weight loss optimization?","volume":"13","author":"Nearing","year":"2017","journal-title":"Surg Obes Relat Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.01.005_bib0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ocl.2018.02.003","article-title":"The role of bariatric surgery in the obese total joint arthroplasty patient","volume":"49","author":"Hooper","year":"2018","journal-title":"Orthop Clin N Am"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218305869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218305869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:59:11Z","timestamp":1758733151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017218305869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0049017218305869"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.01.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes mellitus and osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}